Pharmacogenetics for individualized cancer chemotherapy
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 107 (2) , 155-176
- https://doi.org/10.1016/j.pharmthera.2005.02.005
Abstract
No abstract availableKeywords
This publication has 220 references indexed in Scilit:
- Finishing the euchromatic sequence of the human genomeNature, 2004
- Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracilEuropean Journal Of Cancer, 2004
- PAINT: A Promoter Analysis and Interaction Network Generation Tool for Gene Regulatory Network IdentificationOMICS: A Journal of Integrative Biology, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Activity of Allelic Variants of Pi Class Human Glutathione S-Transferase Toward ChlorambucilBiochemical and Biophysical Research Communications, 2000
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991